[Treatment of respiratory distress syndrome in prematures with xantinol nicotinate].
D000471:Alkalosis / Q000139:chemically induced; D001724:Birth Weight; D002245:Carbon Dioxide / Q000097:blood; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007231:Infant, Newborn; D007234:Infant, Premature; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy* / Q000401:mortality; D013806:Theophylline / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D009539:Nicotinic Acids; D002245:Carbon Dioxide; D013806:Theophylline
Zur Behandlung des Atemnotsyndroms Frühgeborener mit Xantinolnicotinat.